HNK treatment down-regulates HGF-induced c-Met phosphorylation, Ras activation and HO-1 over-expression, and its cross-talk with CNI-induced tumor-promoting pathway(s) in renal cancer cells. The gene discussed is HGF; the disease is renal carcinoma.